A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice

Transcutaneous Administration of Dengue Vaccines

(2020) Robert Andreata-Santos et al.   Viruses-Basel

Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial

(2020) Angus H. Forster et al.   PLOS MEDICINE

Protective Efficacy of a Chimeric Insect-Specific Flavivirus Vaccine against West Nile Virus

(2020) Laura J. Vet et al.   Vaccines

Antigenic Characterization of New Lineage II Insect-Specific Flaviviruses in Australian Mosquitoes and Identification of Host Restriction Factors

(2020) Jessica J. Harrison et al.   mSphere

A Yellow Fever Virus 17D Infection and Disease Mouse Model Used to Evaluate a Chimeric Binjari-Yellow Fever Virus Vaccine

(2020) Kexin Yan et al.   Vaccines

A Zika Vaccine Generated Using the Chimeric Insect-Specific Binjari Virus Platform Protects against Fetal Brain Infection in Pregnant Mice

(2020) Jessamine E. Hazlewood et al.   Vaccines

Dengue

(2019) Annelies Wilder-Smith et al.   LANCET

Microprojection arrays applied to skin generate mechanical stress, induce an inflammatory transcriptome and cell death, and improve vaccine-induced immune responses

(2019) Hwee-Ing Ng et al.   npj Vaccines

Efficient Delivery of Dengue Virus Subunit Vaccines to the Skin by Microprojection Arrays

(2019) David A. Muller et al.   Vaccines

A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus

(2019) Jody Hobson-Peters et al.   Science Translational Medicine

Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope

(2018) Stefan W. Metz et al.   Virology Journal

Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513

(2018) Yee Hwa Wong et al.   Scientific Reports

High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses

(2017) David A. Muller et al.   Scientific Reports

Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine

(2016) Annelies Wilder-Smith et al.   Expert Review of Vaccines

Association of Microvascular Function and Endothelial Biomarkers With Clinical Outcome in Dengue: An Observational Study

(2016) Sophie Yacoub et al.   JOURNAL OF INFECTIOUS DISEASES

Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation

(2016) Eun Kim et al.   EBioMedicine

Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses

(2016) David A. Muller et al.   Scientific Reports

Development of a recombinant, chimeric tetravalent dengue vaccine candidate

(2015) Jorge E. Osorio et al.   VACCINE

Viral RNA Intermediates as Targets for Detection and Discovery of Novel and Emerging Mosquito-Borne Viruses

(2015) Caitlin A. O’Brien et al.   PLoS Neglected Tropical Diseases

Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past

(2015) Rashedul Islam et al.   VIROLOGICA SINICA

Colocalization of Cell Death with Antigen Deposition in Skin Enhances Vaccine Immunogenicity

(2014) Alexandra C.I. Depelsenaire et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

(2014) Maria Rosario Capeding et al.   LANCET

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

(2014) Wanwisa Dejnirattisai et al.   NATURE IMMUNOLOGY

A New Species of Mesonivirus from the Northern Territory, Australia

(2014) David Warrilow et al.   PLoS One

Current issues in dengue vaccination

(2013) Stephen J. Thomas et al.   CURRENT OPINION IN INFECTIOUS DISEASES

A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial

(2013) Anna P. Durbin et al.   JOURNAL OF INFECTIOUS DISEASES

The global distribution and burden of dengue

(2013) Samir Bhatt et al.   NATURE

Intradermal delivery for vaccine dose sparing: Overview of current issues

(2012) Darin Zehrung et al.   VACCINE

Degrees of maturity: the complex structure and biology of flaviviruses

(2012) Theodore C Pierson et al.   Current Opinion in Virology

Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever

(2011) Jorge E. Osorio et al.   VACCINE

The Human Antibody Response to Dengue Virus Infection

(2011) Wahala M. P. B. Wahala et al.   Viruses-Basel

Dengue: a continuing global threat

(2010) Maria G. Guzman et al.   NATURE REVIEWS MICROBIOLOGY

Potent Immunity to Low Doses of Influenza Vaccine by Probabilistic Guided Micro-Targeted Skin Delivery in a Mouse Model

(2010) Germain J. P. Fernando et al.   PLoS One

Dengue Virus Pathogenesis: an Integrated View

(2009) B. E. E. Martina et al.   CLINICAL MICROBIOLOGY REVIEWS